| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Vivian Nogueira Silbiger | Q87684296 |
| P2093 | author name string | Julieta Genre | |
| Camila Xavier Alves | |||
| Diego Marques | |||
| Isabela Samária Fernandes Leite | |||
| Jéssica Nayara Góes de Araújo | |||
| Lara Lima | |||
| Thaísa Cristina Tavares de Melo | |||
| P2860 | cites work | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | Q27860581 |
| MicroRNA signatures in human cancers | Q27860962 | ||
| The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 | ||
| Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation | Q28254300 | ||
| Myc-modulated miR-9 makes more metastases | Q28273857 | ||
| miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro | Q28276065 | ||
| Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer | Q28297295 | ||
| The global burden of cancer: priorities for prevention | Q33575717 | ||
| MicroRNA-181a-mediated downregulation of AC9 protein decreases intracellular cAMP level and inhibits ATRA-induced APL cell differentiation | Q33654191 | ||
| MIR152, MIR200B, and MIR338, human positional and functional neuroblastoma candidates, are involved in neuroblast differentiation and apoptosis | Q34122477 | ||
| Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets | Q34537141 | ||
| MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors | Q35006000 | ||
| MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. | Q35042737 | ||
| miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2 | Q35121352 | ||
| miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies | Q35515926 | ||
| MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid | Q35588426 | ||
| All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment | Q35654471 | ||
| The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. | Q35808837 | ||
| MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells | Q35955244 | ||
| PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia | Q35958274 | ||
| Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs | Q36335774 | ||
| MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. | Q38305314 | ||
| Epigenetic regulation in cancer progression | Q38463713 | ||
| MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation | Q38505096 | ||
| Effects of Pre- and Post-Administration of Vitamin A on the Growth of Refractory Cancers in Xenograft Mice | Q38720643 | ||
| MiR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells | Q38813327 | ||
| Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer | Q38908931 | ||
| The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation | Q38935452 | ||
| MicroRNA-302b-inhibited E2F3 transcription factor is related to all trans retinoic acid-induced glioma cell apoptosis | Q38973972 | ||
| MicroRNA-432 contributes to dopamine cocktail and retinoic acid induced differentiation of human neuroblastoma cells by targeting NESTIN and RCOR1 genes | Q39013012 | ||
| All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity | Q39033095 | ||
| MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. | Q39095883 | ||
| miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid | Q39491088 | ||
| Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer | Q39800540 | ||
| MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. | Q39807104 | ||
| MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets | Q39820130 | ||
| MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. | Q39846851 | ||
| Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis | Q40174254 | ||
| Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells | Q42417341 | ||
| MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF). | Q42604271 | ||
| A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. | Q43609668 | ||
| MicroRNA signature predicts survival and relapse in lung cancer. | Q53507653 | ||
| Retinoic acid-induced survival effects in SH-SY5Y neuroblastoma cells | Q57463488 | ||
| An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens | Q57464305 | ||
| DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid | Q57790453 | ||
| Efficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review | Q58103533 | ||
| Novel Therapies for Relapsed and Refractory Neuroblastoma | Q58582739 | ||
| [Acute Promyelocytic Leukemia: New treatment strategies with ATRA and ATO - AML-BFM-Recommendations] | Q58596635 | ||
| Melatonin Can Strengthen the Effect of Retinoic Acid in HL-60 Cells | Q59133781 | ||
| The protective role of all-transretinoic acid (ATRA) against colorectal cancer development is achieved via increasing miR-3666 expression and decreasing E2F7 expression | Q88717344 | ||
| The role of MicroRNAs in human cancer | Q89700410 | ||
| The new perspectives of targeted therapy in acute myeloid leukemia | Q91121326 | ||
| Molecular mechanism and cytotoxicity of allicin and all-trans retinoic acid against CD44+ versus CD117+ melanoma cells | Q91341353 | ||
| Differential Potentiation of Retinoic Acid Effects against Human Breast Cancer Cells by Unsaturated Fatty Acids | Q91447405 | ||
| RAMS: Remote and automatic mammogram screening | Q91642659 | ||
| Outcome of two patients with bilateral nephroblastomatosis/Wilms tumour treated with an add-on 13-cis retinoic acid therapy - Case report | Q91804139 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 866 | |
| P577 | publication date | 2019-08-30 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Modulation of all-trans retinoic acid-induced MiRNA expression in neoplastic cell lines: a systematic review | |
| P478 | volume | 19 |
| Q93022424 | miR-1254 inhibits progression of glioma in vivo and in vitro by targeting CSF-1 | cites work | P2860 |
Search more.